Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Univariate and multivariate analysis for overall survival

From: Survival analysis of patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed radiotherapy and immunotherapy

 

Group

N

HR

95% CI

p-value

Univariate analysis

     

Age(year)

< 50

52

1.40

0.71–2.79

0.332

 

≥ 50

42

   

Sex

Male

72

1.06

0.49–2.27

0.887

 

Female

22

   

KPS

< 80

33

0.58

0.29–1.15

0.116

 

≥ 80

61

   

Primary tumor location

NPC

73

2.05

0.97–4.37

0.054

 

HNC

21

   

Sites of metastasis

Single

52

1.68

0.83–3.40

0.141

 

Multiple

42

   

No. of metastasis

1

45

2.01

1.24–3.25

0.005

 

2–5

33

   
 

5+

16

   

Chemotherapy

Yes

90

0.70

0.17–2.95

0.624

 

No

4

   

Multivariate analysis

     

Primary tumor location

  

3.26

1.44–7.37

0.005

No. of metastasis

  

2.48

1.47–4.18

0.001

  1. N number, HR hazard ratio, CI confidence interval, KPS Karnofsky performance status, NPC nasopharynx carcinoma, HNC head neck cancer
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us